Noor Ul Ain Rehman
Thu, May 14, 2026 astatine 11:51 AM CDT 1 min read
In its fiscal results for fiscal Q1 2026 released connected May 6, ADMA Biologics, Inc. (NASDAQ:ADMA) reported full gross of $114.5 million, level year-over-year, with ASCENIV gross increasing 28% year-over-year and BIVIGAM gross dropping 54% year-over-year.
ADMA Biologics, Inc. (NASDAQ:ADMA) is simply a biopharmaceutical institution that manufactures, markets, and develops speciality plasma-derived biologics. It conducts operations done the pursuing concern segments: ADMA BioManufacturing and Plasma Collection Center.
While we admit the imaginable of ADMA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 days ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·